Showing results (31-40 of 88) with videos related to
Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2008
Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapyAndrew Reid, Wolfgang Stöhr, A Sarah Walker, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2012
Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and ZimbabweA Sarah Walker, Andrew J Prendergast, Peter Mugyenyi, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized TrialJennifer A Thompson, Cissy Kityo, David Dunn, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2007
Nursing and community rates of Mycobacterium tuberculosis infection among students in Harare, ZimbabweElizabeth L Corbett, Joyce Muzangwa, Kathryn Chaka, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 19, 2015
Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa: Analyses From the EARNEST TrialAndrew Kambugu, Jennifer Thompson, James Hakim, et al.AIDS Research and Human Retroviruses|April 14, 2017
Insulin-Like Growth Factor Is Associated with Changes in Body Composition with Antiretroviral Therapy InitiationKristine M Erlandson, Suzanne P Fiorillo, Sandra Wagner Cardoso, et al.BMC Infectious Diseases|February 23, 2017
The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial dataDavid I Dolling, Ruth L Goodall, Michael Chirara, et al.Antiviral Therapy|February 22, 2007
Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trialFrancis Ssali, Wolfgang Stöhr, Paula Munderi, et al.AIDS (London, England)|June 3, 2015
Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeksChloe L Thio, Laura Smeaton, Kimberly Hollabaugh, et al.The Lancet. HIV|May 13, 2017
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trialNicholas I Paton, Cissy Kityo, Jennifer Thompson, et al.Pageof 9